This is a StreetInsider.com Premium Only Page

VIVUS (VVUS) – StreetInsider.com Reports

Jun 8, 2020 05:26 PM VIVUS (VVUS) Files to Offer Common Stock and Warrants

Jun 2, 2020 07:42 AM VIVUS (VVUS) Announces Updated Agreement with Icahn Enterprises Holdings L.P.

May 27, 2020 12:44 PM VIVUS (VVUS) granted Australian patent for type 2 diabetes mellitus - PatentGrants

May 1, 2020 08:37 AM VIVUS (VVUS) Announces Agreement with IEH Biopharma LLC Granting 30-Day Grace Period to Restructure its Corporate Debt

Apr 1, 2020 09:03 AM VIVUS (VVUS) Announces $11.55 Million Registered Direct Offering of Common Stock

Apr 1, 2020 04:19 AM Increasing unusual option volume: VVUS THRC CNQ BLCM

Mar 31, 2020 10:55 AM Increasing unusual option volume: VVUS CNQ BW PFF OMI TCO GDOT

Mar 31, 2020 09:58 AM Increasing unusual option volume: VVUS OMI

Mar 31, 2020 09:41 AM VIVUS (VVUS) Surges 300% on Telemedicine Move

Mar 31, 2020 07:45 AM VIVUS (VVUS) Accelerates Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care During “Social Distancing”

Mar 4, 2020 06:30 AM Vivus (VVUS) PT Lowered to $1.75 at Wells Fargo

Mar 2, 2020 07:34 AM VIVUS (VVUS) Reports Complete Enrollment in Phase 4 Safety and Efficacy Study of Qsymia in Adolescents

Feb 5, 2020 07:34 AM VIVUS (VVUS) Granted FDA Approval for Improved Formulation of PANCREAZE with 36-Month Shelf Life

Jan 7, 2020 07:35 AM VIVUS (VVUS) Says New Data Further Demonstrate Effectiveness of Qsymia as Weight Management Tool

Dec 31, 2019 07:31 AM VIVUS (VVUS) adopts new stockholder rights plan to replace stockholder rights plan that expired

Dec 18, 2019 07:31 AM VIVUS (VVUS) Announces New Data Supporting Safety and Efficacy of Qsymia in Adolescents with Obesity

Nov 20, 2019 07:32 AM VIVUS (VVUS) Announces New Clinical Data Demonstrate Qsymia is Effective at Reducing Binge Eating in Patients with Binge-Eating Disorder or Bulimia Nervosa

Oct 28, 2019 07:31 AM VIVUS (VVUS) Reports Departures of Eric W. Roberts and Allan L. Shaw from Board

Oct 7, 2019 07:30 AM VIVUS (VVUS) Announces Acceptance of Qsymia Decentralized MAA in Europe

Oct 3, 2019 07:31 AM VIVUS (VVUS) Initiates Pay Down of Secured Debt and Announces Management Changes

Aug 20, 2019 07:36 AM VIVUS (VVUS) Reports New Pilot Clinical Study Shows Patients Receiving Qsymia Before & After LSG Surgery Had Improved Weight Loss/BMI Outcomes

Aug 5, 2019 07:35 AM VIVUS (VVUS) Announces Approval of Qsymia in Republic of Korea

May 30, 2019 09:30 AM Pre-Open Movers 05/30: (BURL) (KEYS) (BITA) Higher; (JILL) (VVUS) (APTO) (more...)

May 29, 2019 05:41 PM After-Hours Movers 05/29: (KEYS) (VEEV) (VRNT) Higher; (VVUS) (APTO) (PVH) (more...)

May 29, 2019 04:44 PM VIVUS (VVUS) Receives FDA Letter Related to Misleading Claims About Efficacy and Risks Associated with Qsymia

May 28, 2019 07:35 AM VIVUS (VVUS) Commences Phase Four Safety and Efficacy Study of Qsymia in Obese Adolescents

Mar 14, 2019 07:38 AM VIVUS (VVUS) Reports Marketing Approval of Avanafil in Russian Federation for Treatment of Erectile Dysfunction

Mar 4, 2019 04:54 PM VIVUS (VVUS) Sees Insider Buying

Jan 14, 2019 07:33 AM VIVUS (VVUS) Says Data Supporting Cardiovascular Safety of its Qsymia Published in The Journal of Clinical Endocrinology & Metabolism

Dec 7, 2018 11:53 AM VIVUS (VVUS) Sees Strong Upside

Oct 29, 2018 07:37 AM VIVUS (VVUS) Appoints Karen Ferrell and Edward A. Kangas to Board

Sep 26, 2018 07:31 AM VIVUS (VVUS) Regains Compliance with Nasdaq Listing Requirements

Sep 11, 2018 09:53 AM VIVUS (VVUS) Halted on LUDP

Sep 10, 2018 07:31 AM VIVUS (VVUS) Plans 1-for-10 Reverse Stock Split

Aug 27, 2018 07:32 AM VIVUS (VVUS) Reports Data Supporting Cardiovascular Safety of Qsymia

Aug 6, 2018 07:32 AM VIVUS (VVUS) Names Kenneth Suh as President

Jul 10, 2018 09:27 AM Pre-Open Movers 07/10: (OCX) (VVUS) (XLRN) Higher; (ISR) (AQXP) (IRBT) Lower (more...)

Jul 10, 2018 07:30 AM VIVUS (VVUS) Announces Positive Results from Phase 1 Clinical Trial of VI-0106 to Treat PAH

Jun 11, 2018 07:32 AM VIVUS (VVUS) Closes Acquisition of PANCREAZE and Previously Announced Financing Transaction

Jun 6, 2018 06:59 AM VIVUS (VVUS) Director Rosenman Buys 50K Shares

May 22, 2018 06:48 AM VIVUS (VVUS) CEO Amos Buys Another 360K Shares

May 18, 2018 10:19 AM VIVUS (VVUS) Adds to Gains as CEO Buys Over 1M Shares

May 18, 2018 09:28 AM Pre-Open Movers 05/18: (QTNT) (AFSI) (CERN) Higher; (AGRX) (ARQL) (CPB) Lower (more...)

May 17, 2018 05:07 PM VIVUS (VVUS) CEO Buys Another 540K Shares

May 16, 2018 06:42 AM VIVUS (VVUS) CEO Buys 540K Shares

May 1, 2018 07:23 AM VIVUS (VVUS) Restructures Debt, Gains Access to New Capital

May 1, 2018 07:15 AM VIVUS (VVUS) Reports Acquisition of PANCREAZE

Apr 30, 2018 04:29 PM VIVUS (VVUS) Names John Amos as CEO

Dec 26, 2017 04:06 PM VIVUS (VVUS) Announces Thomas King as Interim CEO

Nov 7, 2017 04:13 PM VIVUS (VVUS) Tops Q2 EPS by 7c